D.E. Shaw & Co’s Opko Health OPK Stock Holding History

D.E. Shaw & Co’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-70,000	Closed	-$704K	–	3675
2015 Q4	$704K	Buy	+70,000	New	+$702K	﹤0.01%	2877

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

D.E. Shaw & Co's OPK Position: Q2 2025 in Review

D.E. Shaw & Co sold out of Opko Health (OPK) in Q2 2025, closing a stake of 4,731,688 shares — an estimated $7.85M sold.

D.E. Shaw & Co first reported a position in OPK in Q4 2013 and held it in 42 quarters. The position peaked at $23M in Q2 2015. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2025.

D.E. Shaw & Co reported no remaining Opko Health position as of Q2 2025 after selling out during the quarter.
D.E. Shaw & Co sold 4,731,688 Opko Health shares in Q2 2025, an estimated $7.85M.
D.E. Shaw & Co first reported a position in Opko Health in Q4 2013 and held it in 42 quarters.
D.E. Shaw & Co's Opko Health position peaked at $23M in Q2 2015.
222 funds tracked by Wall St. Rank held Opko Health as of Q2 2025.

Based on D.E. Shaw & Co's 13F filing for Q2 2025, filed 14 Aug 2025.